Propel Bio Management, LLC
- SEC CIK
- 0001969764
- Latest filing
- Aug 13, 2026
ABEO holding history
Abeona Therapeutics Inc. in every 13F filed by Propel Bio Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABEO overviewAll 13F holders of ABEOFull Q2 2026 holdings
- Shares (Q2 2026)
- 983,070
- Value
- $6.08M
- % of portfolio
- 3.2%
- Quarters held
- 9
- Since Q2 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 983,070 | $6.08M | 3.2% | −346,829−26.1% | Reduced | Holders |
| Q1 2026 | 1,329,899 | $6.01M | 3.8% | +499,119+60.1% | Added | Holders |
| Q4 2025 | 830,780 | $4.38M | 3.7% | −143,242−14.7% | Reduced | Holders |
| Q3 2025 | 974,022 | $5.14M | 5.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 974,022 | $5.53M | 6.7% | +350,000+56.1% | Added | Holders |
| Q1 2025 | 624,022 | $2.97M | 3.5% | 00.0% | Unchanged | Holders |
| Q4 2024 | 624,022 | $3.48M | 3.5% | 00.0% | Unchanged | Holders |
| Q3 2024 | 624,022 | $3.94M | 2.3% | −624,022−50.0% | Reduced | Holders |
| Q2 2024 | 1,248,044 | $5.29M | 3.4% | +1,248,044 | New | Holders |